HPR225 Impact of the 2021 US Federal X-Waiver Practice Guideline Change on the Prescribing of Buprenorphine and Naltrexone for Treating Opioid Use Disorder in Medicaid Population
Abstract
Authors
J Qian X Xue
J Qian X Xue
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now